PROCEPT BioRobotics Corporation
PRCT
$25.79
$0.110.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.94% | 42.76% | 48.41% | 55.28% | 56.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.94% | 42.76% | 48.41% | 55.28% | 56.57% |
| Cost of Revenue | 22.41% | 36.64% | 25.44% | 28.18% | 10.02% |
| Gross Profit | 6.05% | 46.31% | 64.37% | 76.40% | 105.47% |
| SG&A Expenses | 20.66% | 38.23% | 37.97% | 39.39% | 33.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.15% | 31.84% | 26.43% | 33.82% | 20.25% |
| Operating Income | -57.49% | -3.41% | 17.29% | 0.76% | 33.32% |
| Income Before Tax | -60.40% | -2.08% | 23.60% | 4.70% | 32.78% |
| Income Tax Expenses | -48.37% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.28% | -2.08% | 23.60% | 4.70% | 31.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.28% | -2.08% | 23.60% | 4.70% | 31.44% |
| EBIT | -57.49% | -3.41% | 17.29% | 0.76% | 33.32% |
| EBITDA | -60.66% | -2.25% | 19.40% | 1.90% | 35.35% |
| EPS Basic | -52.00% | 4.74% | 28.87% | 11.50% | 35.59% |
| Normalized Basic EPS | -54.05% | 4.72% | 28.88% | 11.48% | 36.85% |
| EPS Diluted | -52.00% | 4.74% | 28.87% | 11.50% | 35.59% |
| Normalized Diluted EPS | -54.05% | 4.72% | 28.88% | 11.48% | 36.85% |
| Average Basic Shares Outstanding | 4.15% | 7.14% | 7.41% | 7.66% | 6.42% |
| Average Diluted Shares Outstanding | 4.15% | 7.14% | 7.41% | 7.66% | 6.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |